Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD
No-Receipt date
2009-01750 - 14/05/2009
No-Filing date
20090401274 - 14/05/2009
No-Granting date
3068997 - 15/05/2009
No-EPO application date
03751859.4 - 14/08/2003
No-EPO granting date
1542668 - 15/04/2009
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2009 - 12/06/2009
Expiration date
15/08/2023
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US404713 P20/08/2002/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/496
A61K 47/12
A61P 25/18
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
588772
OTSUKA PHARMACEUTICAL CO., LTD.
2-9, KANDA TSUKASA-MACHI, CHIYODA-KU
TOKYO 101-8535
JAPAN
Inventors
Code
Firstname
Surname
667832
NERURKAR, MANOJ
667833
NARINGREKAR, VIJAY
667834
DOMINICK, MARK
Representatives
Code
Firstname
Surname
Address
Town
Zip
2849
MARIA
PAPANIKOLAOU
M. ASIAS 10, ANO PEYKI
PEFKI (ATTIKIS)
15121
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2897
ALKISTIS-EIRINI
MALAMI
SKOUFA 52
ATHINA (ATTIKIS)
10672
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
12/02/2015
Μεταβίβαση (7e802)
ΑΡ.ΠΡΩΤ. 141/14-1-2015,ΚΩΔ.ΠΛΗΡ. 987
283945 Bristol-Myers Squibb Company Route 206 and Province Line Road P.O. Box 4000 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Princeton NJ 08543-4000
588772 Otsuka Pharmaceutical Co., Ltd. 2-9, Kanda Tsukasa-machi, Chiyoda-ku ΙΑΠΩΝΙΑ Tokyo 101-8535
Title Instruments
Date
Operation
Descreption
3/5/2020 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 02/2020 Αρ. Πρωτ. ΓΔ 456 / 05-03-2020
Payments history
16 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).